Amedisys Inc financial data

Symbol
AMED on Nasdaq
Industry
Services-Home Health Care Services
Location
3854 American Way, Suite A, Baton Rouge, LA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 112 % +8.92%
Debt-to-equity 85 % +0.37%
Return On Equity 7.15 % +2867%
Return On Assets 3.95 % +2854%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 32.8M shares +0.36%
Common Stock, Shares, Outstanding 32.8M shares +0.36%
Entity Public Float 2.6B USD -13.3%
Weighted Average Number of Shares Outstanding, Basic 32.7M shares +0.37%
Weighted Average Number of Shares Outstanding, Diluted 33.1M shares +0.93%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 588M USD +5.65%
General and Administrative Expense 848M USD +6.12%
Costs and Expenses 2.17B USD +5.53%
Operating Income (Loss) 148M USD -12.1%
Nonoperating Income (Expense) -13.5M USD +88.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 135M USD +160%
Income Tax Expense (Benefit) 51.9M USD +3.53%
Net Income (Loss) Attributable to Parent 82.9M USD +3032%
Earnings Per Share, Basic 2.53 USD/shares +2430%
Earnings Per Share, Diluted 2.53 USD/shares +4117%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 245M USD +214%
Accounts Receivable, after Allowance for Credit Loss, Current 301M USD -5.8%
Other Assets, Current 13M USD -60.8%
Assets, Current 580M USD +24.1%
Property, Plant and Equipment, Net 42M USD +5.98%
Operating Lease, Right-of-Use Asset 85.1M USD -3.1%
Intangible Assets, Net (Excluding Goodwill) 99.7M USD -3.8%
Goodwill 1.24B USD 0%
Other Assets, Noncurrent 87.7M USD +3.87%
Assets 2.14B USD +5.51%
Accounts Payable, Current 32.1M USD -7.06%
Employee-related Liabilities, Current 138M USD +8.97%
Accrued Liabilities, Current 146M USD +4.68%
Liabilities, Current 486M USD +3.82%
Long-term Debt and Lease Obligation 344M USD -6.11%
Deferred Income Tax Liabilities, Net 48M USD +35.6%
Operating Lease, Liability, Noncurrent 59.3M USD -4.13%
Other Liabilities, Noncurrent 886K USD -46.3%
Liabilities 939M USD +0.51%
Retained Earnings (Accumulated Deficit) 812M USD +11.4%
Stockholders' Equity Attributable to Parent 1.15B USD +10.4%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 1.2B USD +9.78%
Liabilities and Equity 2.14B USD +5.51%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -6.54M USD -125%
Net Cash Provided by (Used in) Financing Activities -8.55M USD +85%
Net Cash Provided by (Used in) Investing Activities -3.07M USD -107%
Common Stock, Shares Authorized 60M shares 0%
Common Stock, Shares, Issued 38.3M shares +0.53%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 245M USD +161%
Interest Paid, Excluding Capitalized Interest, Operating Activities 8.19M USD +23.1%
Deferred Tax Assets, Valuation Allowance 5.4M USD +3.85%
Deferred Tax Assets, Gross 76.4M USD -1.55%
Operating Lease, Liability 89M USD -13.6%
Payments to Acquire Property, Plant, and Equipment 2.67M USD +97.8%
Lessee, Operating Lease, Liability, to be Paid 96.8M USD -11.7%
Property, Plant and Equipment, Gross 134M USD +14.4%
Operating Lease, Liability, Current 26.4M USD +1.26%
Lessee, Operating Lease, Liability, to be Paid, Year Two 26.1M USD -15.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 29.5M USD -18.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure +29.4%
Deferred Income Tax Expense (Benefit) 2.59M USD -6.42%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 7.8M USD +18.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 19.7M USD -5.29%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 13.2M USD +3.94%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 6.14M USD +7.8%
Deferred Tax Assets, Net of Valuation Allowance 71M USD -1.93%
Interest Expense 32.3M USD +25.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%